CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 350 enrolled
Drug / intervention
Hydromorphone +1 moredrug
Likely dose
Hydromorphone 0.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01429285
NCT01429285Phase 4Completed
CompareCT.gov

Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain

Montefiore Medical Center·interventional·Posted Sep 7, 2011·Updated May 18, 2018

In Brief

A Phase 4 clinical trial evaluating Hydromorphone and Usual care for Pain. Completed, enrolled 350 participants across 1 site.

Detailed Summary

The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2011
Enrollment StartJul 1, 2009
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 14.8 years ago

Interventions

Hydromorphonedrug

0.5 mg IV hydromorphone followed by an optional 0.5 mg IV dose

Usual caredrug

Attending administers any IV opioid in any dose he chooses